Skip Navigation
Search Menu
News and Publications

In This Section      
Print This Page

Current News Releases

Current News Releases

Released: January 16, 2017

Epigenetic changes, not DNA mutations, drive some metastasis


A multicenter team of researchers reports that a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells. Those advantages, the researchers say, let such cancer cells thrive in organs like the liver and lungs, which receive a sugar-rich blood supply.

Released: January 12, 2017

Study shows how and why hairlike structures on cells are lost


Many of our cells are equipped with a hairlike “antenna” that relays information about the external environment to the cell, and scientists have already discovered that the appearance and disappearance of these so-called primary cilia are synchronized with the process of cellular duplication, called mitosis. Now, cell biologists at Johns Hopkins report the discovery of new information about how this “hair loss” and cell duplication are linked through the dramatic clipping of the tips of the cilia — what the scientists dub decapitation — that begins their disassembly.

Released: January 12, 2017


Young scientists interested in bladder cancer research can compete for up to two awards totaling $100,000 from a joint effort between the Johns Hopkins Greenberg Bladder Cancer Institute and the Bladder Cancer Advocacy Network (BCAN).

Released: January 11, 2017

New heart disease “staging” system focuses on those previously considered at low risk


Experts at Johns Hopkins and New York’s Mount Sinai Health System have published a suggested new plan for a five-stage system of classifying the risk of heart attack in those with heart disease, one they say puts much-needed and long-absent focus on the risks faced by millions of Americans who pass so-called stress tests or have less obvious or earlier-stage danger signs.

Released: January 10, 2017

Insight into cellular mechanisms illuminates biological target for PTSD therapy


Experiments in mice by researchers at Johns Hopkins suggest that if the goal is to ease or extinguish fearful emotional memories like those associated with post-traumatic stress disorder, alcohol may make things worse, not better. Results of their study demonstrate, they say, that alcohol strengthens emotional memories associated with fearful experiences and prevents mice from pushing aside their fears.

Released: January 9, 2017


Johns Hopkins researchers who conducted a dozen focus groups with 70 straight and gay/bisexual Hispanic and African-American males ages 15 to 24 report that gaining a better understanding of the context in which young men grow up will allow health care providers to improve this population’s use of sexual and reproductive health care.

Released: January 9, 2017


Johns Hopkins researchers along with academic and drug industry investigators say they have identified a new biological target for treating spinal muscular atrophy. They report they have evidence that an experimental medicine aimed at this target works as a “booster” in conjunction with a drug called nusinersen that was recently FDA-approved to improve symptoms of the disorder in mice.

Released: January 5, 2017


Johns Hopkins Medicine today announced a collaborative agreement with Under Armour Inc. that introduces evidence-based science along with expert insights to the Under Armour Connected Fitness™ platform, which includes a suite of health and fitness applications: UA Record™, MapMyFitness®, MyFitnessPal® and Endomondo™.

Released: January 5, 2017


Robert Wood, M.D., director of pediatric allergy and immunology and professor of pediatrics at the Johns Hopkins University School of Medicine, is available to discuss the National Institute of Allergy and Infectious Diseases' new Guidelines for the Prevention of Peanut Allergy and their implications.

Released: January 5, 2017

Discovery could explain widespread acquired resistance among patients treated with immune checkpoint blockade drugs


Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells. The study, conducted by researchers on the cells of five of their patients treated at the Johns Hopkins Kimmel Cancer Center, is described online Dec. 28 in Cancer Discovery.

Released: January 4, 2017


Inez Stewart, M.Ed., has assumed the role of senior vice president of human resources for the Johns Hopkins Health System.

Released: January 3, 2017


The Department of Physical Medicine and Rehabilitation at Johns Hopkins Medicine is expanding to continue improving the quality of patient care. New facilities are needed not only to address a growing demand for health care but also to advance the standard of compassionate, individualized care at Johns Hopkins Medicine.

Released: December 30, 2016

Survey assesses both risky behaviors and positive outcomes


In a survey of almost 2,000 people who said they had had a past negative experience when taking psilocybin-containing “magic mushrooms,” Johns Hopkins researchers say that more than 10 percent believed their worst “bad trip” had put themselves or others in harm’s way, and a substantial majority called their most distressing episode one of the top 10 biggest challenges of their lives

Released: December 23, 2016

Four-year "J-CHiP" study helps hospitals operate more efficiently while helping patients in their homes


When people with chronic health problems couldn't get around town to their doctors' appointments, a four-year Johns Hopkins program brought the appointments to them.

Released: December 22, 2016

2016 winners announced across the health system


Johns Hopkins Medicine hosted its second annual awards program, the Johns Hopkins Medicine Clinical Awards for Physicians and Care Teams, honoring 42 physicians and care teams who embody the best in clinical excellence. The program was launched by the Office of Johns Hopkins Physicians, and awards were open to providers who practice within Johns Hopkins Medicine, including Johns Hopkins Community Physicians locations.

Released: December 22, 2016

Link between sleep/wake cycles and core body temperature discovered in mice


A clump of just a few thousand brain cells, no bigger than a mustard seed, controls the daily ebb and flow of most bodily processes in mammals — sleep/wake cycles, most notably. Now, Johns Hopkins scientists report direct evidence in mice for how those cell clusters control sleep and relay light cues about night and day throughout the body.

Released: December 22, 2016

Animal study suggests “best practice” for preserving the immune system


In experiments on mice with a form of aggressive brain cancer, Johns Hopkins researchers have shown that localized chemotherapy delivered directly to the brain rather than given systemically may be the best way to keep the immune system intact and strong when immunotherapy is also part of the treatment.

Released: December 21, 2016

Approach lengthens life of mice with skin cancer


By combining two treatment strategies, both aimed at boosting the immune system’s killer T cells, Johns Hopkins researchers report they lengthened the lives of mice with skin cancer more than by using either strategy on its own. And, they say, because the combination technique is easily tailored to different types of cancer, their findings — if confirmed in humans — have the potential to enhance treatment options for a wide variety of cancer patients.

Released: December 20, 2016


Experimenting with human cells and mice, Johns Hopkins researchers have found that a genetic mutation that alters a protein called NOD1 may increase susceptibility to human cytomegalovirus (CMV) infection. CMV is a common pathogen that infects almost 60 percent of adults in the U.S., according to the Centers for Disease Control and Prevention (CDC), and can lead to devastating developmental defects in fetuses and severe disease in people with weakened immune systems.

Released: December 19, 2016

Finding could lead to treatment for Kabuki syndrome in people


Experimenting on mice with a genetic change similar to that found in people with a rare inherited disease called Kabuki syndrome,  Johns Hopkins scientists report that a very low-carbohydrate diet can “open up” DNA and improve mental function.